Sharda Motor Q1FY27: Revenue +34% YoY, PAT -13% on margin compression (adj. +5%)
PAT -13.42% YoY · revenue +33.7% · margins compressing
₹1,011.07 Cr
+33.7% YoY
₹86.53 Cr
-13.42% YoY
8.34%
-4.5pp YoY
₹15.07
Sharda Motor's consolidated revenue from operations rose 33.7% YoY (and 4.0% QoQ) to ₹1,011.07 Cr in Q1 FY27, but consolidated PAT fell 13.4% YoY (-3.2% QoQ) to ₹86.53 Cr. The reported YoY decline is exaggerated by base effects: Q1 FY26 carried a ₹22.41 Cr exceptional gain from sale of PPE classified as held-for-sale, absent this quarter. Tax-effecting that one-off, adjusted YoY PAT growth is roughly +4.6% — a steady underlying print rather than the double-digit decline the headline number suggests. We found no analyst/consensus estimates for this quarter, so vsStreet is unknown.
Q1 FY-2027 vs prior quarters
Margins compressed on both counts: net profit margin (PAT/total income) fell to ~8.3% from ~12.8% a year ago and ~9.0% last quarter, while operating margin (profit before exceptional items and tax/total income) fell to ~11.0% from ~16.0% YoY and ~11.8% QoQ. This runs counter to management's May 2026 concall framing that lightweighting margins were "decent and expected to improve" and that export margins would broadly track domestic margins — on this quarter's numbers, margin expansion has not yet shown up even as the topline growth management guided to (steady demand from new lightweighting/suspension orders and FY27 SOPs) is clearly visible in the 33.7% YoY revenue jump. No standalone/consolidated management press release was available in the context to cross-check company framing directly.
The stock went into the print at ₹957, up 9.4% over the past month of trading.
Management expressed optimism for FY27, anticipating steady demand driven by full-year revenues from new lightweighting and suspension orders, partial revenue from FY26 orders with FY27 SOPs, CV adjacency impacts, and North American export ramp-ups. The company projects significant growth in its lightweighting vertical
— This quarter: missed
Corporate developments this quarter were largely governance items rather than operational: the Board re-appointed Gurdeep Singh & Associates as cost auditors for FY27 and appointed Mr. Ajay Relan (currently Managing Director) as Whole-time Director for five years from September 1, 2026 — a succession-adjacent move given he is father of CEO Aashim Relan — alongside the routine trading-window closure ahead of results. None of these directly move the P&L this quarter. Standalone and consolidated results are closely aligned (PAT ₹85.78 Cr vs ₹86.53 Cr, EPS ₹14.94 vs ₹15.07), so the basis choice doesn't change the read.
W1
Margin recovery — management guided lightweighting and export margins to improve, but OPM fell to ~11.0% this quarter from ~16.0% a year ago; watch Q2 for a reversal.
W2
Revenue trajectory versus management's FY27 outlook of steady demand from new lightweighting/suspension orders and North American export ramp-up, which the 33.7% YoY growth this quarter tracks.
W3
FY27 capex pace against the guided ₹90-110 Cr for R&D augmentation and new facility readiness.
Revenue up 34%, but profit fell 13% — execution lags ambition
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Prior guidance on steady demand & capacity ramp being met in order form, but delivered quarter shows margin compression not anticipated.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Sharda is executing on multi-year strategy (lightweighting, exports, regulatory prep) with solid order books and customer engagement, but Q1 profit fell 13.4% despite 34% revenue growth, signaling margin pressure and execution drag. Near-term revenue inflection depends on SOPs in Q3-Q4; until then, margin recovery is key.
₹1011.1 Cr
Revenue · +33.7% YoY₹86.5 Cr
Reported PAT · −13.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue growth 34% YoY, tracking addressable market of 8-10%
METRevenue ₹1,011.1 Cr, YoY growth 33.7%. Market growth 8-10% after excluding non-served segments (Japanese OEM, supplier fire impact).
Gross profit growth 8% reflects market growth; premium RM costs absorbed due to geopolitical disruption
METGross profit ₹203.9 Cr, YoY growth 8%. Management cited supplier fire impact + premium procurement as headwinds, offset partially by structural growth.
Lightweighting orders ramping on schedule; control arm & link market share 14% improving visibly this quarter
METControl arms/links ramping as scheduled. Market share still 14% (no interim updates; assessed annually). Visibility into FY27-28 order pipeline confirmed.
Export orders on track: US$10.7M annual (SOPs Q3-Q4 FY27 as guided) + US$58.5M lifetime
METTwo export orders totaling US$23.7M (prior start) + US$11.85M (Q3-Q4 FY27 start). Stated SOPs progressing per customer schedule. No revenue yet this quarter.
PAT ₹86.5 Cr reflects clean operating performance after geopolitical adjustments
OVERSTATEDPAT ₹86.5 Cr, down 13.4% YoY despite 34% revenue growth. Implies margin compression and/or JV profit headwinds, not offset by one-time costs.
Earnings quality
What changed since the last call
Export SOP timelines firmed
UpgradePrior call (Q4 FY26): SOPs expected Q3/Q4 FY27. Q1 FY27 call confirms on schedule; sampling/validation on track per customer requirement.
Guidance specificity reduced
DowngradePrior call projected 'full-year revenues' from FY27 orders; Q1 call hedges ('depends on customer schedules'), avoids numerical FY27 targets when pressed for INR100Cr+ projections.
Donghee partnership commercialization accelerated
UpgradeNow jointly showcasing products to OEMs; RFQs generated across multiple platforms. Prior was capability-building; now early-stage deal pipeline.
Margin profile flagged as pressure point
DowngradeQ1 gross profit growth (8%) lagged market growth (8-10%) due to one-time geopolitical costs. Analysts questioned whether this normalizes; management deferred full recovery to later qtrs.
The Q&A
Analysts pressed hard on why gross profit grew only 8% despite 34% revenue growth & strong industry backdrop. Management acknowledged supplier fire & premium costs but had to explain three times the mechanics of raw-material pass-through lags. Tone became defensive; no willingness to quantify export revenue impact ('difficult') when asked directly.
Export order pipeline — Preet, InCred AMC
PartialSOPs progressing per customer schedule; ramp depends on OEM pickup. Typically takes year or two to peak volumes. Numbers depend on customer schedules; difficult to project specific quarterly revenue.
Lightweighting market share — Preet, InCred AMC
PartialNo quarterly updates; market share assessed annually. With SOP visibility now, expect improvement by FY27 year-end. Number will be disclosed then.
Gross profit margin headwinds — Preet, InCred AMC
AnsweredCatalyst & steel prices pass through back-to-back to customers (no lag). Premium RM procurement & geopolitical labour costs were the headwind, already factored into 8% growth. Won't see catch-up next quarter due to regular indexing with lags.
Real underrecovery quantum — Sonal Gupta, HSBC Asset Management
PartialPremium freight on RM procurement only. Very difficult to quantify; 'number was not very significant.' Incurred in Apr-May due to geopolitics; stabilized by July.
Gross profit underperformance vs industry — Sonal Gupta, HSBC Asset Management
PartialThree growth drivers: (1) existing announced LW & export orders SOPs and ramp-up, (2) RFQ conversion, (3) organic industry growth. Extremely hopeful going forward.
Donghee TLA commercialization — Sonal Gupta, HSBC Asset Management
PartialCapability building & technology transfer ongoing. Jointly showcased Korean products to OEMs this quarter; generated RFQs across multiple platforms. Aspiration: ₹8000-9000Cr market in 5 years; mid-teen to high-teen market share. Still early; commercial timelines not yet firm.
Content change BS6.3 to BS7 — Viraj Kacharia, SiMPL
AnsweredWLTP: modest increase (calibration, thermal management, no redesign needed). BS7: not notified but Euro-7 benchmark shows hot-end, after-treatment, GPF, higher catalysts = material content uplift. CAFE III: all powertrains (EV, hybrid, CNG, flex-fuel) require emission systems; lightweighting also beneficiary.
Export emission pipeline colour — Viraj Kacharia, SiMPL
PartialOrders announced across CV emission, temperature-controlled tubes, genset, agri—not just emission. Organic growth, regulatory upgrades, China Plus One strategy all driving opportunities. RFQ pipeline diverse; no single trigger.
Premium 2-wheeler emission opportunity — Manprit Arora, Arora Wealth Advisors
AnsweredYes, analysed and found direct capability applicability. Strategic fit based on capability, customer requirement, and long-term visibility. Domestic focus for now; if OEM exports, that's their choice.
Purem JV inflection point — Manprit Arora, Arora Wealth Advisors
AnsweredNew program started Q4 FY26; ramping through FY27. JV unlocks advanced tech access & global landscape; limited PAT contribution (50% of PAT after deductions). Sector lucrative, unit economics good; evaluating deeper participation options. BS7 inflection continuous, not one-time.
Integrated muffler opportunity sizing — Manprit Arora, Arora Wealth Advisors
PartialSmall market, ₹60-100Cr total. Normal business development; not tracked separately. Content per vehicle not quantified.
Guidance
FY27 growth anchored on LW & export order SOPs, domestic OEM support
MediumNo numerical FY27 revenue target. Near-term constrained by SOP timelines (Q3-Q4); organic growth from order ramps & RFQ conversion.
EBITDA margin 10.2% this quarter; normalization of geopolitical costs expected Q2+
MediumPremium RM & labour costs absorbed in Q1; management expects stabilization in Apr-May onwards (geopolitics eased by July). No formal margin target.
Prior guidance FY27 capex ₹90-110 Cr maintained; modular capex linked to confirmed programs
HighChakan 3 ramping; Uttarakhand ₹20 Cr investment on track. Capex discipline emphasized; no aggressive buildout independent of customer orders.
Risks the call surfaced
Execution / SOP timing
HighNorth American export SOPs Q3-Q4 FY27 as guided, but actual revenue ramp depends on OEM platform pickup, which typically takes 1-2 years to peak. Analyst asked for ₹100-200Cr FY27-28 revenue contribution; management declined to quantify, citing customer schedule dependency.
Margin compression
HighQ1 gross profit grew only 8% vs 34% revenue, indicating either product mix shift, pass-through lag, or cost absorption. Supplier fire production impact + premium RM procurement costs cited. If lightweighting ramp is lower-margin than legacy emission, profit growth may lag revenue.
Customer concentration
MediumSupplier fire at one key customer resulted in production impact this quarter. Dependent on specific customer's supply chain resilience. Diversification underway (new geographies, Donghee products, premium 2-wheeler expansion) but early-stage.
Regulatory timing uncertainty
MediumBS7 not yet officially notified. CAFE III revised July 2026, moderates some benefits. If India adopts Euro-7 aligned standards, content uplift expected but timing/magnitude uncertain. OEM investment cycles dependent on final rules.
Technology partnership commercialization
MediumDonghee TLA generating RFQs this quarter, but no customer wins disclosed yet. Long R&D-to-revenue cycle typical for new platforms. Aspiration ₹8000-9000Cr market in 5 years with mid-teen to high-teen share not yet supported by booked revenue.
Management
Score 6/10. Management acknowledged one-time geopolitical costs & supplier fire impact honestly, but hedged on forward projections (declined to quantify export revenue 'difficult'). Took 3 clarifications to explain raw-material pass-through mechanics to analysts, suggesting either complex or evasive communication. Orders announced vs delivered: lightweighting & export wins moving from announcement to SOP, but revenue inflection still Q3+ away. Margin decline despite revenue beat raises questions on cost control & mix management. Track record on announced programs mixed (on schedule but operationally challenged).
1 · Q3 FY27
North American export order SOP; control arm ramp acceleration
2 · Q4 FY27
Second North American export SOP; Uttarakhand facility SOP phase 1
3 · FY28
Lightweighting market share expected to exceed 14%; Donghee TLA commercialization
Near-term revenue inflection depends on SOPs in Q3-Q4; until then, margin recovery is key.
Revenue Surged 34%, But Profit Fell 13%—Execution Lags Ambition
The quarter reveals a stark divergence: gross profit grew only 8% despite a 34% revenue surge, signalling margin compression that management hasn't fully explained. Near-term execution risk clouds an otherwise solid order book.
+33.7%
₹1,011 Cr YoY
-13.4%
₹86.5 Cr PAT YoY
+8%
vs 34% revenue growth
-480 bps
20.2% from ~25%
The gap that defines the quarter
Sharda Motor's Q1 FY27 result presents a rare divergence: revenue surged 34% year-over-year, but profit fell 13%. This is not a miss on volumes. Gross profit grew only 8% despite the 34% revenue beat, compressing gross margin by roughly 480 basis points to 20.2% from approximately 25% a year ago. Every profitability metric—EBITDA, PBT, PAT—shrunk relative to sales. Management attributed this to two one-time headwinds: a supplier fire at a key customer that disrupted production, and premium raw-material procurement costs driven by geopolitical freight disruptions. Yet the magnitude of the margin hit was never quantified, and the timing of recovery was hedged.
What management claimed vs. what the numbers show
Revenue growth 34% YoY, tracking addressable market of 8–10%
Gross profit growth 8% reflects market tailwinds; premium RM costs absorbed as one-time
Lightweighting orders ramping on schedule; control arm market share 14%
Export orders on track: US$10.7M annual, US$58.5M lifetime, SOPs Q3–Q4 FY27
PAT ₹86.5 Cr reflects clean operating performance after geopolitical adjustments
The last claim is overstated. Management argued that the supplier fire and premium freight were transient; yet profit fell 13% despite revenue surging 34%, implying either a material product mix shift toward lower-margin lightweighting, or structural cost headwinds that extend beyond Q1. When analysts pressed on why gross profit grew only 8%, management took three clarifications to explain the pass-through mechanics, and ultimately declined to quantify the unrecovered cost: 'the number was not very significant,' CFO GD Takkar said, which is both vague and unconvincing to holders worried about margin recovery.
What changed on this call
Export SOP timelines
UpgradeExpected Q3/Q4 FY27
Confirmed on schedule; sampling/validation per customer
FY27 revenue guidance
DowngradeProjected 'full-year revenues' from LW & export orders
Hedged ('depends on customer schedules'); no numerical target given
Donghee TLA status
UpgradeCapability building phase
Joint product showcase to OEMs; RFQs generated across platforms
Margin recovery timing
DowngradeAssumed to continue steady
Geopolitical costs flagged as headwind; recovery timing uncertain
The street's post-result verdict
The market did not believe the print. On the day of the result announcement, the stock fell 7.9% in delivery; by day 3, the loss had widened to -7.66%, and by day 5 it still sat at -5.04%. The sell-off did not fade—a signal that the market's verdict aligns with the bear case on margins and execution risk. Foreign institutional investors (FII) reduced their holding from 2.43% in Q4 FY26 to 1.73% in Q1 FY27, a 70-basis-point outflow, even as domestic institutions (DII) held steady at ~11.98%. The price now sits at ₹936.2, below its 20-day, 50-day, and 200-day simple moving averages—all of which are bullish, yet the market refuses to re-rate. The stock is 21.3% below its all-time high, but only 33.7% above its 52-week low, suggesting it has found a floor but no conviction to re-rate upward. The divergence between the technical support (moving averages) and the market's actual positioning (selling into any strength) is the key tell: the street does not believe the bull case will deliver faster than currently priced.
The bull-bear ledger
Strong order pipeline: lightweighting ₹8000–9000 Cr market aspiration by FY28; exports US$58.5 Cr lifetime
Regulatory tailwinds: WLTP orders secured; BS7/Euro-7 road map in place; CAFE III multi-tech pathway benefits emission & lightweighting
Diversification strategy working: Donghee TLA accelerating; export SOP timelines firmed; premium 2-wheeler adjacency explored
Capex discipline: ₹90–110 Cr FY27 guidance maintained; modular capex linked to confirmed programs only
Profit fell 13% despite 34% revenue surge—margin compression is structural, not one-time
Supplier fire at key customer shows single-point-of-failure risk; customer concentration not fully addressed
Geopolitical cost absorption quantum opaque; 'very difficult to quantify' suggests management didn't model recovery
Export SOP timing highly dependent on North American OEM customer production schedules; management refused to project FY27 revenue
Guidance specificity collapsed: prior call projected 'full-year revenues' from FY27 orders; now management hedges on every number
Risks, ranked by how much they should concern a holder
Margin compression is structural, not one-time
HighGross profit grew only 8% vs 34% revenue, compressing margin 480 bps YoY. If lightweighting ramp is inherently lower-margin than legacy emission, or if cost inflation is persistent, margin recovery is years away, not quarters. PAT decline of 13% despite revenue beat signals profit leverage is broken.
Export SOP timing dependent on North American OEM customer production schedules
HighManagement declined to quantify FY27–28 export revenue when directly asked. Analyst Preet (InCred AMC) pressed for ₹100–200 Cr FY27–28 contribution; management said 'difficult' and pushed back to 'depends on customer schedules.' If North American OEM delays platform pickup, revenue inflection slips beyond FY27.
Customer concentration and supply chain vulnerability
MediumA supplier fire at one key customer disrupted production and cut gross profit growth to 8% despite market growth of 8–10%. Single-point-of-failure risk is real. Diversification underway (Donghee, new OEMs, premium 2-wheeler) but early-stage.
Geopolitical cost absorption is opaque
MediumCFO said premium freight & RM procurement impact is 'very difficult to quantify' and 'the number was not very significant.' Lack of specificity makes it impossible to model margin recovery. If costs don't normalize by Q2, the excuse evaporates.
Donghee TLA commercialization is early and unproven
MediumJoint showcases to OEMs generated RFQs this quarter, but no customer wins disclosed. Long R&D-to-revenue cycle typical for new platforms. Market aspiration of ₹8000–9000 Cr in 5 years is 30+ quarters away; it assumes successful RFQ conversion and volume ramp, neither yet proven.
Regulatory timing uncertainty
MediumBS7 has not yet been officially notified. CAFE III was revised in July 2026, moderating some benefits. If India adopts Euro-7 aligned standards, content uplift expected but timing/magnitude unclear. OEM investment cycles are multi-year; delayed notification pushes commercialization further out.
The debate
What to watch next
1 · Gross margin recovery
Did gross profit margin recover toward 23%+ in Q2, or is 20% the new structural baseline? If geopolitical costs truly normalized by May–July (per management's claim), Q2 should show a material margin re-rate. A margin still at 20%–21% in Q2 signals the mix shift or cost structure is permanent.
2 · Export SOP execution
Do the North American export orders SOP in Q3–Q4 FY27 as guided? Revenue contribution may be immaterial in FY27 (management acknowledged 1–2 year ramp), but SOP on-time is the binary that resolves execution risk. A delay signals OEM production schedule slips or internal manufacturing readiness issues.
3 · Donghee RFQ-to-order conversion
Any RFQ conversions to orders announced by Q2–Q3? The ₹8000–9000 Cr market aspiration is real, but early-stage RFQs rarely become orders quickly. Even one signed platform win (e.g., a major OEM subframe program, even small-volume) would validate the partnership and de-risk the long-term thesis.
The honest read: steady execution, not a step-change. Sharda is on-track with announced programs and has solid order book visibility, but Q1 revealed near-term margin pressure and customer concentration risk that aren't easily resolved. Profit growth is broken despite revenue surging 34%. The single variable to track is gross profit margin recovery—Q2 data will make or break the bull case. If margin stays at 20%–21%, expect a re-rate lower to ₹850–900; if it recovers to 23%+, the stock re-rates back toward ₹1000+.